Patents by Inventor Sarah Bonnet

Sarah Bonnet has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Purified polypeptide comprising or consisting of a C-terminus MSP1 antigen from carrying a Glycosyl-phosphatidyl-inositol group (GPI)
    Patent number: 8188213
    Abstract: The present invention relates to a purified polypeptide comprising or consisting of a C-terminus Merozoite Surface Protein 1 (MSP1) antigen from Plasmodium falciparum carrying a Glycosyl-phosphatidyl-inositol group (GPI), an immunogenic composition and a vaccine against a Plasmodium infection comprising said purified polypeptide.
    Type: Grant
    Filed: January 12, 2007
    Date of Patent: May 29, 2012
    Assignee: Institut Pasteur
    Inventors: Shirley Longacre, Sarah Bonnet, Thierry Fontaine, Charles Roth, Faridabano Nato
  • PURIFIED POLYPEPTIDE COMPRISING OR CONSISTING OF A C-TERMINUS MSP1 ANTIGEN FROM PLASMODIUM FALCIPARUM CARRYING A GLYCOSYL-PHOSPHATIDYL-INOSITOL GROUP (GPI)
    Publication number: 20100255038
    Abstract: The present invention relates to a purified polypeptide comprising or consisting of a C-terminus MSP1 antigen from Plasmodium falciparum carrying a Glycosyl-phosphatidyl-inositol group (GPI), an immunogenic composition and a vaccine against a Plasmodium infection comprising said purified polypeptide.
    Type: Application
    Filed: January 12, 2007
    Publication date: October 7, 2010
    Applicants: CENTRE NATIONAL DE LA RECHERCHE SCIENT, INSTITUT PASTEUR
    Inventors: Shirley Longacre, Sarah Bonnet, Thierry Fontaine, Charles Roth, Faridabano Nato
  • Carboxypeptidases B from anopheles gambiae. compositions comprising them, vaccine applications and use as therapeutical targets
    Publication number: 20050260219
    Abstract: The present invention provides two carboxypeptidase B enzymes from Anopheles gambiae and homologs thereof. The present invention also provides compositions and vaccines containing the carboxypeptidase B enzymes, as well as antibodies directed thereto and various methods of using the same. The methods of the present invention include a method of blocking Plasmodium development and a method of identifying compounds that inhibit carboxypeptidase B activity.
    Type: Application
    Filed: April 21, 2005
    Publication date: November 24, 2005
    Applicant: INSTITUT PASTEUR
    Inventors: Catherine Lavazec, Catherine Bourgouin, Christian Boudin, Sarah Bonnet